Ketonal (Ketoprofen)

Ketoprofen blocks the activity of cyclooxygenase enzymes (COX‑1 and COX‑2), which are needed to produce prostaglandins—molecules that trigger inflammation, pain, and fever. By lowering prostaglandin levels, ketoprofen diminishes the inflammatory response and the perception of pain.

The exact dose of Ketonal is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, age, renal and hepatic function, and other individual factors. Healthcare professionals follow local prescribing guidelines to set the appropriate strength and frequency.

Ketoprofen is generally avoided in the third trimester of pregnancy because it may affect fetal cardiovascular development. Use during earlier stages or while breastfeeding should only occur if the prescriber judges that the potential benefits outweigh the risks. Consultation with a healthcare provider is essential.

To request Ketonal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Ketonal (ketoprofen) offers a relatively rapid onset of analgesia and strong anti‑inflammatory activity compared with some older NSAIDs like ibuprofen. Its potency is similar to diclofenac, but individual response and tolerability can vary. Choice of NSAID often depends on patient comorbidities, risk profile and clinician preference.

Ketonal should be stored below 25 °C in its original packaging, protected from moisture and direct light. Maintaining a stable room‑temperature environment helps preserve the stability of the injectable solution and prevents degradation.

Ketonal is supplied as an injectable solution for intramuscular or intravenous administration. The route, injection site, and infusion rate are determined by the prescribing clinician, who follows aseptic technique and appropriate dosing guidelines for the specific indication.

Serious risks include gastrointestinal bleeding or ulcer perforation, severe allergic reactions such as anaphylaxis, cardiovascular events like myocardial infarction or stroke, and significant renal impairment. Patients should be monitored for signs of these complications, especially if they have pre‑existing risk factors.

Ketonal is contraindicated in patients with known hypersensitivity to ketoprofen or other NSAIDs, those with active gastrointestinal bleeding, severe heart failure, or severe renal or hepatic impairment. It should also be avoided in the third trimester of pregnancy and used with caution in the elderly.